Adam Gigi, Adam Ana-Maria, Robu Silvia, Harabor Valeriu, Harabor Anamaria, Nechita Aurel, Marin Denisa Batir, Morariu Ionela-Daniela, Cioanca Oana, Vasilache Ingrid-Andrada, Hancianu Monica
Faculty of Pharmacy, "Grigore T. Popa" University of Medicine and Pharmacy, 16 Universitatii Street, 700115 Iasi, Romania.
Department of Pharmaceutical Sciences, Faculty of Medicine and Pharmacy, 'Dunarea de Jos' University, 800216 Galati, Romania.
Pharmaceuticals (Basel). 2023 Jul 10;16(7):988. doi: 10.3390/ph16070988.
(1) Background: Chronic renal disorders (CRD) are associated with significant comorbidities and necessitate complex therapeutic management. As time passed, (PF) became a promising therapeutic option for CRD. The aim of this systematic review and meta-analysis was to outline the therapeutic effects of PF extracts on various models of immunoglobulin a (IgA) nephropathy; (2) Methods: Medline, Embase, and Cochrane databases were used to find relevant studies. All prospective interventional studies that evaluated the effect of PF extract versus placebo on rat models of chronic renal disorders were assessed according to the international guidelines; (3) Results: Our search yielded 23 unique records, out of which only five were included in the analysis. Our results showed that administration of PF extracts led to a statistically significant reduction in proteinuria and PCNA levels in rats that received high doses of the extract as well as in the PCNA level and DNA synthesis in rats that received low doses of the extract. The evaluated outcomes benefited from a low degree of heterogeneity; (4) Conclusions: Some of the evaluated outcomes were significantly reduced by both high and low doses of extracts from . Further studies are needed to determine the exact effect over IgA nephropathy in human subjects.
(1) 背景:慢性肾脏疾病(CRD)与多种严重合并症相关,需要复杂的治疗管理。随着时间推移,(PF)成为CRD一种有前景的治疗选择。本系统评价和荟萃分析的目的是概述PF提取物对各种免疫球蛋白A(IgA)肾病模型的治疗效果;(2) 方法:使用Medline、Embase和Cochrane数据库查找相关研究。所有评估PF提取物与安慰剂对慢性肾脏疾病大鼠模型影响的前瞻性干预研究均按照国际指南进行评估;(3) 结果:我们的检索产生了23条独特记录,其中仅5条纳入分析。我们的结果表明,给予PF提取物导致接受高剂量提取物的大鼠蛋白尿和增殖细胞核抗原(PCNA)水平以及接受低剂量提取物的大鼠PCNA水平和DNA合成在统计学上显著降低。评估结果的异质性程度较低;(4) 结论:高剂量和低剂量的提取物均使某些评估结果显著降低。需要进一步研究以确定对人类IgA肾病的确切影响。